Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 186

The DOI matches its Crossref record.

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Open access
Kim, Dae-Young, Joo, Young-Don, Lim, Sung-Nam, Kim, Sung-Doo, Lee, Jung-Hee, Lee, Je-Hwan, Kim, Dong Hwan (Dennis), Kim, Kihyun, Jung, Chul Won, Kim, Inho, Yoon, Sung-Soo, Park, Seonyang, Ahn, Jae-Sook, Yang, Deok-Hwan, Lee, Je-Jung, Lee, Ho-Sup, Kim, Yang Soo, Mun, Yeung-Chul, Kim, Hawk, Park, Jae Hoo, Moon, Joon Ho, Sohn, Sang Kyun, Lee, Sang Min, Lee, Won Sik, Kim, Kyoung Ha, Won, Jong-Ho, Hyun, Myung Soo, Park, Jinny, Lee, Jae Hoon, Shin, Ho-Jin, Chung, Joo-Seop, Lee, Hyewon, Eom, Hyeon-Seok, Lee, Gyeong Won, Cho, Young-Uk, Jang, Seongsoo, Park, Chan-Jeoung, Chi, Hyun-Sook, Lee, Kyoo-Hyung·2015·Blood

Abstract

Key Points: Nilotinib plus multiagent chemotherapy was feasible and showed a comparable outcome to previous results with imatinib for Ph-pos ALL. The achievement of deep MR with nilotinib at postremission correlated well with the clinical outcomes for Ph-pos ALL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2015-03-636548

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 186

Metadata

Authors
Kim, D.-Y., Joo, Y.-D., Lim, S.-N., Kim, S.-D., Lee, J.-H., Lee, J.-H., Kim, D. H. (., Kim, K., Jung, C. W., Kim, I., Yoon, S.-S., Park, S., Ahn, J.-S., Yang, D.-H., Lee, J.-J., Lee, H.-S., Kim, Y. S., Mun, Y.-C., Kim, H., Park, J. H., Moon, J. H., Sohn, S. K., Lee, S. M., Lee, W. S., Kim, K. H., Won, J.-H., Hyun, M. S., Park, J., Lee, J. H., Shin, H.-J., Chung, J.-S., Lee, H., Eom, H.-S., Lee, G. W., Cho, Y.-U., Jang, S., Park, C.-J., Chi, H.-S., & Lee, K.-H.
Venue
Blood
Published
2015-08-06
Volume
126
Issue
6
Pages
746-756
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1506738181
Cited by
186
References
0
FWCI
18.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia. https://app.cochat.ai/papers/10.1182/blood-2015-03-636548
The paper
Kim, D.-Y., Joo, Y.-D., Lim, S.-N., Kim, S.-D., Lee, J.-H., Lee, J.-H., Kim, D. H. (., Kim, K., Jung, C. W., Kim, I., Yoon, S.-S., Park, S., Ahn, J.-S., Yang, D.-H., Lee, J.-J., Lee, H.-S., Kim, Y. S., Mun, Y.-C., Kim, H., . . . Lee, K.-H. (2015). Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia. Blood. https://doi.org/10.1182/blood-2015-03-636548

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.